Aim: To investigate the effects of M3, a derivative of huperzine A, on the apoptosis induced by sodium nitroprusside (SNP) in PC12 cells. Methods: Cell viability was detected using MTT method. Apoptosis was examined with annexin V/prodium iodide (PI) stain. The levels of reactive oxygen species (ROS) were measured using fluorophotometric quantitation. The amount of malonaldehyde (MDA) was determined with MDA detection kits. The expression of caspase-3 and Hsp70 were analyzed using Western blotting. Results: Exposure of PC12 cells to SNP (200 μmol/L) for 24 h decreased the cell viability to 69.0% of that in the control group. Pretreatment with M3 (10 μmol/L) or huperzine A (10 μmol/L) significantly protected the cells against SNP-induced injury and apoptosis; the ratio of apoptotic bodies in PC12 cells was decreased from 27.3% to 15.0%. Pretreatment with M3 (10 μmol/L) significantly decreased ROS and MDA levels, and increased the expression of Hsp70 in the cells. Quercetin (10 μmol/L) blocked the protective effect of M3, while did not influence on that of huperzine A. Conclusion: M3 protects PC12 cells against SNP-induced apoptosis, possible due to ROS scavenging and Hsp70 induction.
Introduction
Alzheimer's disease (AD) and Parkinson's disease (PD) are multifaceted, progressive neurodegenerative disorders that occur mainly in older age groups; however, the incidence of these diseases has increased in younger populations in recent years. Although these two disorders are characterized by different clinical manifestations and pathological phenomena, they are both categorized by a selective loss of neurons. Free radical-induced oxidative stress, mitochondrial dysfunction, and excitotoxic processes have been suggested to play a key role in the loss of neurons [1, 2] . Hsp70, a member of the heat shock protein family, functions as an ATP-dependent molecular chaperone in protein folding, multi-protein complex assembly, transmembrane transport, and protein degradation [3] . This protein is also part of an inducible system that aids in cell survival by preventing and/or repairing stress-induced protein damage during and after detrimental environmental stresses, such as free-radical accumulation [4] . Pytlowany et al used PC12 cells to compare the protective effects of huperzine A (HupA) derivative M3 and HupA on sodium nitroprusside (SNP)-induced apoptosis [5] . PC12 cells are derived from a rat pheochromocytoma cell line and can acquire neuron-like properties, such as neurite extension, when exposed to nerve growth factor (NGF). These cells are often used to study PD because NGF-treated and untreated cells synthesize, store, secrete, and take up dopamine by processes that are similar to those of dopaminergic neurons [6] . PC12 cells are also used to study AD because they express β-amyloid (Aβ) precursor protein (APP), in keeping with the mRNA and protein levels found in cortical neurons [7] . HupA, which is isolated from the herb Huperzia serrata, has been shown to be a highly effective, selective, and reversible acetylcholinesterase (AChE) inhibitor. The use of HupA as a therapeutic treatment for early or mild stages of AD may be due to additional mechanisms other than the reversible inhibition of AChE in the central nervous system. For example, HupA may target oxidative stress, Aβ-associated neurotoxicity, APP processing, and NGF [8] . The capacity of AChE to hydrolyze acetylcholine is not involved in the aforementioned mechanisms [9] . Therefore, we sought to identify derivatives of HupA that retain a similar level of AChE inhibition but yield an increase in cell protection. Due to the rigid molecular (Figure 1 ) was identified as huperzine A 8α,15α-epoxide using physical and chemical data collected through multiple analyses, such as HRMS, 1D NMR, 2D NMR, and IR. Although the IC 50 value of M3 on AChE inhibition was established to be higher than that of HupA [10] , the remarkable effect of protecting PC12 cells from oxidative stress was observed in our present screening.
Materials and methods

Materials and reagents
M3 was prepared as previously described [10] . HupA and SNP were bought from the National Institute of the Control of Pharmaceutical and Biological Products. Quercetin and Hoechst 33342 were purchased from Sigma. These compounds were dissolved in DMSO and diluted by PC12 medium. An annexin V/propidium iodide (PI) staining kit was bought from Beijing Biosea Biotechnology Company. Dichlorofluorescein diacetate (DCFH-DA) and MDA kits were bought from Beyotime Institute of Biotechnology. The anti-Hsp70 antibody and antimouse secondary antibody were bought from Santa Cruz Biotechnology. The anti-caspase-3 (17 kDa) antibody was bought from Cell Signaling Technology. The anti-β-actin antibody was bought from Sigma.
Cell culture and treatment PC12 cells, purchased from the American Tissue Type Collection, were grown in 75-cm 2 tissue culture flasks in DMEM supplemented with 5% heat-inactivated fetal bovine serum (FBS), 10% equine serum (ES), penicillin (100 IU/mL), streptomycin (100 mg/L), and L-glutamine (2 mmol/L). Cultures were maintained at 37 °C in 95% air-5% CO 2 in a humidified incubator and passaged every 3 to 4 d. PC12 cells in logarithmic phase were seeded into 96-well or 6-well plates coated with 0.1 mg/mL poly-L-lysine (Sigma) and allowed to grow for at least 24 h. Different concentrations of M3 and HupA (0.1, 1, and 10 μmol/L) were added to the culture media for 1 h followed by addition of SNP (200 μmol/L) for 24 h. In some experiments, PC12 cells were pretreated with 10 μmol/L quercetin and 10 μmol/L M3 for 1 h and were exposed to 200 μmol/L SNP for the next 24 h.
MTT assay PC12 cells were cultured at a density of 6000 cells per well in 96-well plates. MTT (5 mg/mL) was added to each well after the aforementioned treatments and the plates were incubated for 4 h. After centrifugation, the supernatant was removed from each well, and DMSO (100 μL) was added. After 30 min, the absorbance was recorded with a microplate reader (BioRad model 550) at a wavelength of 570 nm. Each experiment was performed in triplicate.
Detection of apoptosis PC12 cells were cultured at a density of 30 000 cells per well in 6-well plates. Cells were harvested by being digested in 0.25% trypsin after treatment, stained with annexin V for 20 min, and PI for another 10 min at 37 °C before detection using flow cytometry (EPICS XL, Beckman Coulter, USA). To stain the DNA, cells were incubated with Hoechst 33342 (10 μg/mL) diluted in phosphate-buffered saline (PBS) for 10 min at room temperature. Cells were then observed by the IN Cell Analyzer 1000 (GE Healthcare, USA).
Measurement of reactive oxygen species (ROS)
Intracellular accumulation of ROS was measured using fluorophotometric quantitation. The cells were cultured with M3 or HupA (10 μmol/L) for 1 h before exposure to SNP (200 μmol/L) for 24 h. The harvested cells were subsequently stained with DCFH-DA for 30 min at 37 °C. The cell suspension was dispensed into 96-well black plates. DCFH-DA reacts with ROS and is converted to dichlorofluorescein (DCF). The fluorescence from the DCF was analyzed using a Spectra microplate fluorescence reader (Max Gemini XS, MD, USA) with the excitation wavelength set at 488 nm and the emission wavelength set at 525 nm.
Estimation of lipid peroxidation
MDA reacts with thiobarbituric acid (TBA) to produce a fluorescent product. Levels of MDA were measured in PC12 cell lysates with a microplate reader at a wavelength of 535 nm. PC12 cells were treated with M3 1 h prior to exposure to SNP and left to grow to more than 90% confluence in 75-cm 2 plates. Cells were harvested and washed with PBS after 24 h. The method described in the MDA detection kit was employed from Nanjing Jiancheng Bioengineering Institute, Nanjing, China.
Protein assay
After a 1-h treatment with M3 and 24 h exposure to SNP, cells were rapidly washed with PBS and lysed on ice in a lysis buffer (pH=8.0) containing 50 mmol/L Tris-HCl, 150 mmol/L NaCl, 1% NP-40, 1 mmol/L PMSF, 1 mmol/L EDTA, 50 mmol/L NaF, 1 mmol/L DTT, 1 mg/L aprotinin and 1% Triton X-100. Protein concentrations were measured with a BCA kit (Vigorous). The lysates were solubilized in an SDS sample buffer, separated with 15% SDS-PAGE, and transferred 
Results
The neurotoxicity of SNP on PC12 cells Before studying the protective effects of M3, we analyzed the toxicity of SNP on PC12 cells. PC12 cells treated with different concentrations of SNP for 24 h displayed a decrease in the production of formazan dye in a dose-dependent manner. Exposure to 200 μmol/L of SNP induced moderate injury to the cells when compared with the control group. This concentration of SNP was used to compare the neuroprotective effects of M3 and HupA (Figure 2 ).
Pre-incubation with M3 and HupA protected PC12 cells from SNP-induced injury Exposure to 200 μmol/L of SNP for 24 h decreased the viability of PC12 cells to 69.0%±4.8% compared with the control group. Pre-incubation with M3 or HupA for 1 h attenuated the injury induced by SNP in a dose-dependent manner. This effect was statistically significant at a concentration of 10 μmol/L (P<0.05). The cell viability after pre-incubation with M3 was 84.1%±2.7% of the control, while the cell viability after pre-incubation with HupA was 77.1%±3.5% of the control (P<0.05, Figure 3 ). There was no significant difference in cell viability between the M3 and HupA pre-treated groups (P>0.05).
M3 and HupA attenuated the SNP-induced apoptosis of PC12 cells
Analysis of an annexin V/PI stain using flow cytometry and Hoechst 33342 stain with a fluorescence microscope revealed that pretreatment with HupA or M3 significantly decreased the apoptosis of PC12 cells induced by SNP. M3 pretreatment alone showed no effect on apoptotic bodies or the nuclear morphology of PC12 cells. Pre-treatment with HupA and M3 (10 μmol/L) attenuated nuclear fragmentation and chromatin condensation, and inhibited apoptosis at the early and intermediate stages of SNP exposure. There was no statistically significant difference in the percentage of apoptotic bodies between the M3 and HupA groups (Figure 4 ).
M3 inhibited the production of SNP-induced ROS in PC12 cells
DCFH-DA is hydrolyzed to DCFH by intracellular esterases, which is subsequently oxidized by ROS to DCF, which is a fluorescent compound. The fluorescence intensity is directly proportional to the amount of ROS generated from SNP exposure. Using an excitation wavelength of 488 nm and an emission wavelength of 525 nm, the mean fluorescence intensity increased to 183.5%±18.3% in the SNP-treated group compared with the control group. Pre-incubation with 10 μmol/L of M3 or 10 μmol/L of HupA resulted in a decrease in the mean fluorescence intensity to 142.3%±20.2% or 132.0%±6.5%, respectively, compared with the SNP-treated group ( Figure 5 ). There was no statistically significant difference in the levels of ROS between the M3 and HupA groups (P>0.05).
Treatment with M3 decreased SNP-induced MDA accumulation in PC12 cells
MDA, formed by degradation of polyunsaturated lipids by Quercetin blocked the protective effect of M3 treatment on SNPinduced apoptosis in PC12 cells Quercetin, a HSP biosynthesis inhibitor, was used to confirm if Hsp70 was involved in the protective effect of M3. As shown in Figure 7A , quercetin attenuated the protection conferred from M3 pretreatment on SNP-induced apoptosis while showing almost no effect on HupA-treated cells. As displayed in Figure 7B , treatment with HupA failed to significantly change the expression of Hsp70 compared with the expression of the SNP-exposed group. In M3 pretreated cells, the expression of Hsp70 increased to 212.5%±26.7% compared with control group. Caspase-3 expression remarkably increased in PC12 cells after exposure to SNP for 24 h, and pre-incubation with HupA and M3 for 1 h reversed this effect. Quercetin had no effect on the activation of caspase-3 in the control or HupA pretreated group, but it significantly increased the expression of caspase-3 in the M3 pretreated group (P<0.05).
Discussion
Oxidative stress is recognized as an important mechanism in several neurodegenerative diseases. It has been proven that the activity of inducible nitric oxide synthases (iNOS) was increased in the brains of AD patients [11] . Free-radical production and nitration of endogenous biomolecules are the two main reasons that accumulation of nitric oxide (NO) induces cell loss [12] . In this study, SNP was used to induce the apoptosis of PC12 cells in order to evaluate potential neuroprotective compounds. Exposure to SNP in vitro could partially mimic the oxidative stress observed in the brains of neurodegenerative patients [5] . We found that, similar to the effect of HupA, pretreatment with M3 attenuated the apoptosis induced by SNP in PC12 cells. Although M3 and HupA showed a similar level of ROS scavenging, it seems that this was not the only mechanism involved in the protective effects of M3. Indeed, treatment with M3 induced the expression of Hsp70 in a timedependent manner, unlike HupA. Hsp70, a member of the heat shock protein family, functions as a chaperone in protein folding, which can reduce abnormal protein aggregation [13, 14] .
Overproduction of Hsp70 was shown to strongly protect brain cells from ischemia/reperfusion injuries both in vitro and in vivo [15] . Some of the anti-apoptotic activity of Hsp70 could be attributed to its ability to suppress the activity of JUN-kinase or Bid proteins [16, 17] . Thus, the decreased activation of caspase-3 in the M3 treated group might be due to the inhibition of the JNK/Bim pathway by the induction of Hsp70.
NO exposure has been established to induce Hsp70 expression in order to protect cells from tumor necrosis factorinduced apoptosis [18] . In our study, expression of Hsp70 could not save the PC12 cells from SNP-induced apoptosis. However, the M3 pretreatment remarkably increased the Hsp70 response without causing detrimental effects.
To confirm whether the induction of Hsp70 by M3 was responsible for its protective effects, quercetin, which is an HSP biosynthesis inhibitor, was used. Our results showed that pretreatment with quercetin attenuated the protective effect of M3 against SNP-induced apoptosis. This finding suggests that the protective effect of M3 was mediated, at least partly, by increasing the expression of Hsp70. However, quercetin failed to attenuate the protection of HupA on SNP-induced apoptosis, suggesting that the protective mechanism of HupA might have little interaction with Hsp70. Therefore, it appears that the protective mechanisms for these two compounds are different.
Taken together, M3 was similar to HupA with respect to free-radical scavenging. However, M3 treatment was able to elevate the expression of Hsp70 and decrease the expression of active caspase-3. M3 may activate the stress response without causing detrimental effects, thereby allowing the cells to survive under lethal conditions. Pretreatment with HupA also displayed ROS scavenging in PC12 cells exposed to SNP, but the presence of other protective mechanisms is not clear. Our research suggests that the distinctive chemical structure of HupA and its derivatives may be related to its anti-apoptotic properties. Further studies will concentrate on optimizing and analyzing these chemical structures in order to facilitate the design of novel anti-neurodegenerative drugs. 
